Recent A News
- Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29 • Business Wire • 05/02/2024 03:45:00 PM
- Padraig McDonnell Assumes Agilent CEO Role • Business Wire • 05/01/2024 12:45:00 PM
- Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution • Business Wire • 05/01/2024 12:00:00 PM
- Agilent Names Simon May to Lead Diagnostics and Genomics Group • Business Wire • 04/29/2024 12:45:00 PM
- Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results • PR Newswire (Canada) • 04/18/2024 08:31:00 PM
- Agilent Receives Scientists' Choice Awards for Sustainability • Business Wire • 04/16/2024 12:00:00 PM
- Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay • Business Wire • 04/15/2024 12:00:00 PM
- Agilent Brings Great Science to Life at Analytica 2024 • Business Wire • 04/04/2024 12:00:00 PM
- Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics • Business Wire • 04/03/2024 12:00:00 PM
- Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence • Business Wire • 04/02/2024 12:00:00 PM
- Agilent Launches New Advanced Dilution System to Increase Lab Efficiency • Business Wire • 04/01/2024 12:00:00 PM
- Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan • Business Wire • 03/14/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 06:08:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 05:05:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 03:04:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 08:41:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 07:05:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 07:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 07:02:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:05:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 07:13:03 PM
- Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers • Business Wire • 02/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:06:38 PM
- Agilent Reports First-Quarter Fiscal Year 2024 Financial Results • Business Wire • 02/27/2024 09:05:00 PM
- Agilent Announces Cash Dividend of 23.6 Cents per Share • Business Wire • 02/21/2024 09:20:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM